A versatile technology platform that converts drugs, including vaccines, small and large molecules, and biologics, into dry powder formulations for inhalation, with improved absorption for delivery to the eyes, nose, and skin.

An inhaled dry powder formulation of voriconazole for the treatment and prevention of invasive pulmonary aspergillosis, reducing systemic exposure and drug-drug interactions.